Phase III Multicenter Randomized trial of CPX-351 (Cytar

Project: Research project

Project Details

Description

Phase III Multicenter Randomized trial of CPX-351 (Cytarabine: Daunorubicin) Liposome injections vs Cytarabine and Daunorubicin in Patients 60-75 years of age with untreated high risk (secondary) AML
StatusFinished
Effective start/end date10/30/123/30/20

Funding

  • CELATOR PHARMACEUTICALS, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.